Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays the Effisayil™ ON study record for long-term spesolimab treatment in people with generalized pustular psoriasis, including study design, eligibility, outcome measures, and participating locations. The study is listed as active but not recruiting.
    Difference
    65%
    Check dated 2026-11-09T07:31:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.2 to v3.8.0; the study record remains unavailable on the error page.
    Difference
    0.2%
    Check dated 2026-11-02T07:53:26.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH transition update, including a notice about using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T09:43:48.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T08:12:36.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T08:13:26.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous detailed content. The detailed study information and related navigation are effectively hidden behind an access-block page.
    Difference
    16%
    Check dated 2026-09-21T08:34:55.000Z thumbnail image

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.